Pseudouridine: A Biochemical Marker for Cancer

  • Filiberto Cimino
  • Tommaso Russo
  • Alfredo Colonna
  • Francesco Salvatore


Although some progress has been made in clarifying the molecular basis underlying neoplastic transformation, antineoplastic treatment is still based on the effort toward the removal of all neoplastic cells. In this respect, the most important requirement for the effectiveness of treatment is the precocious diagnosis, possibly in the preclinical period. Clinical, radiological and endoscopic examinations are often poorly sensitive and in some cases invasive and dangerous, thus efforts are focused to obtain a precocious tumor detection by biochemical or biological assays.


High Performance Liquid Chromatography Rous Sarcoma Virus High Performance Liquid Chromatogra High Performance Liquid Chromato Chick Embryo Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams W. S., Davis F. and Nakatani M., 1960, Purine and pyrimidine excretion in normal and leukemic subjects, Am. J. Med. 28: 726.PubMedCrossRefGoogle Scholar
  2. Adler M. and Gutman A. B., 1959, Uridine isomer (5-ribosyluracil) in human urine, Science 130: 862.PubMedCrossRefGoogle Scholar
  3. Arena F., Ciliberto G., Ciampi S., and Cortese R., 1978, Purification of pseudouridylate synthetase I from Salmonella typhimurium, Nucleic Acid Res. 5: 4523.PubMedCrossRefGoogle Scholar
  4. Borek E., Baliga B. S., Gehrke C.W., Kuo K. C., Belman S., Troll W., Waalkes T. P., 1977, High turnover rate of transfer RNA in tumor tissue, Cancer Res. 37: 3362.PubMedGoogle Scholar
  5. Brand R. C., Klootwijk J., Siburn C. P. and Planta R. J., 1979, Pseudouridylation of yeast ribosomal precursor RNA, Nucleic Acids Res. 7: 121.PubMedCrossRefGoogle Scholar
  6. Busch H., Reddy R., Rothblum L. and Choi Y. C., 1982, SnRNAs, snRNPs, and RNA processing, Ann. Rev. Biochem. 51: 617.Google Scholar
  7. Chambers R. W., The chemistry of pseudouridine, 1966, Prog. Nucleic Acid Res. Mol. Biol. 5: 349.PubMedCrossRefGoogle Scholar
  8. Chang S.Y., Lakings D. B., Zumwalt R. W., Gehrke C. W. and Waalkes T. P., 1974, Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography, J. Lab. Clin. Clin. Med. 83: 816.Google Scholar
  9. Cimino F., Costanzo F., Russo T., Colonna A., Esposito F., Salvatore F., 1982, Modified nucleosides from transfer ribonucleic acid as tumor markers, in:“The Biochemistry of S-Adenosylmethionine and related compounds”, E. Usdin, R. T. Borchardt, C.R. Creveling, eds., MacMillan, London.Google Scholar
  10. Colonna A. and Kerr S. J., 1980, The nucleus as the site of tRNA methylation, J. Cell. Physiol. 103: 29.PubMedCrossRefGoogle Scholar
  11. Colonna A., Duilio A., Russo T., Salvatore F., and Cimino F., 1983a, tRNA pseudouridine synthase activity in malignant cells. Abstracts of 15th F.E.B.S. Meeting, Bruxelles, p. 243.Google Scholar
  12. Colonna A., Russo T., Esposito F., Salvatore F., Cimino F.,1983b Determination of pseudouridine and other nucleosides in human blood serum by high performance liquid chromatography, Anal. Biochem. 130: 19.PubMedCrossRefGoogle Scholar
  13. Cooper I. A., Wray G. R. and Murphy T. L., 1977, Urinary excretion patterns of tRNA degradation products: a marker of Hodgkin’s cell metabolism? Europ. J. Cancer 13: 1309.Google Scholar
  14. Cortese R., Kammen H. O., Spengler S. J., and Ames B. N., 1974a, Biosynthesis of pseudouridine transfer ribonucleic acid, J. Biol. Chem. 249: 1103.PubMedGoogle Scholar
  15. Cortese R., Landsberg R., Von der Haar R. A., Umbarger H. E. and Ames B. N., 1974b, Pleiotropy of His T mutants blocked in pseudouridine synthesis in tRNA: leucine and isoleucinevaline operon, Proc. Natl. Acad. Sci. U.S.A., 71: 1857.PubMedCrossRefGoogle Scholar
  16. Esposito F., Ammendola R., Russo T., and Cimino F., 1983, Abstract of 29th Meeting of S.I.B., Saint Vincent, Italy, p. 509.Google Scholar
  17. Fujimura S. and Shimizu M., 1977, Enhanced activity of tRNA pseudouridine synthetase in Yoshida ascites sarcoma. Biochim. Biophys. Res. Commun. 79: 763.CrossRefGoogle Scholar
  18. Gauss D.H. and Sprinzl, 1983, Compilation of tRNA sequences, Nucleic Acid Res., 11: r1.Google Scholar
  19. Gehrke C. W., Kuo K. C., Davis G. E., Suits R. D., Waalkes T. P.,E. Borek, 1978, Quantitative high-performance liquid chromatography of nucleoside in biological materials. J. Chromatogr. 150: 455.PubMedCrossRefGoogle Scholar
  20. Gehrke C. W., Kuo K. C., Waalkes T. P., Borek E., 1979, Pattern of urinary excretion of modified nucleosides, Cancer Res. 39: 1150.PubMedGoogle Scholar
  21. Green C. J., Kammen H. O., and Penhoet E. E., 1982, Purification and properties of a mammalian tRNA pseudouridine synthase, J. Biol. Chem. 257: 3045.PubMedGoogle Scholar
  22. Gross L., 1970, “Oncogenic viruses”, Pergamon Press, London.Google Scholar
  23. Harada F., Sawyer R. C., and Dahlberg J. E., 1975, A primer ribonucleic acid for initiation of in vitro Rous sarcoma virus deoxyribonucleic acid synthesis, J. Biol. Chem. 2500: 3483.Google Scholar
  24. Harada F., Peters G. G., and Dahlberg J. E., 1979, The primer tRNA for Moloney murine leukemia virus DNA synthesis, J. Biol. Chem. 254: 10979.PubMedGoogle Scholar
  25. Heldman D. A., Grever M. R., Trewyn R. W., 1983, Differential excretion of modified nucleosides in adult acute leukemia, Blood 61: 291.PubMedGoogle Scholar
  26. Hogan A., Creuss-Callaghan A. and Fennelly J. J., 1970, Studies of pseudouridine change in chronic lymphatic leukemia during therapy, Ir. J. Med. Sci. 3: 505.CrossRefGoogle Scholar
  27. Hughes D. G. and Maden B. E. H., 1978, The pseudouridine contents of the ribosomal ribonucleic acids of three vertebrate species, Biochem. J. 171: 781.PubMedGoogle Scholar
  28. Kuo K. C., Gehrke C. W., Mc Cune R. A., Waalkes T. P. and Borek E.,1978, Rapid, quantitative high-performance liquid column chromatography of pseudouridine, 145: 383.Google Scholar
  29. Levine L. Waalkes T. P., and Stolbach L., 1975, Serum levels of N,N -dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy, J. Natl. Cancer Inst. 54:341.PubMedGoogle Scholar
  30. Matsushita T., and Davis F. F., 1971, Studies on pseudouridylic acid synthetase from various sources. Biochim. Biophys. Acta 238: 165.PubMedGoogle Scholar
  31. Melton D. A., De Robertis E. M., and Cortese R., 1980, Order and intracellular location of the events involved in the maturation of the spliced RNA, Nature 284: 143.PubMedCrossRefGoogle Scholar
  32. Ming Chu T., 1982, “Biochemical markers for cancer”, Marcel Dekker Inc., New York and Berlin.Google Scholar
  33. Park R. W., Holland J. F. and Jenkins R., 1962, Urinary purines in leukemia, Cancer Res. 22: 469.PubMedGoogle Scholar
  34. Pinkard K. J., Cooper I. A., Motterman R. and Turner C. N., 1972, Purine and pyrimidine excretion in Hodgkin’s disease, J. Natl. Cancer Inst. 49: 27.PubMedGoogle Scholar
  35. Randerath K., Yu C. T. and Randerath E., 1972, Base analysis of ribopolynucleotides by chemical tritium labeling: a methodological study with model nucleosides and purified tRNA species, Anal. Biochem. 48: 172.PubMedCrossRefGoogle Scholar
  36. Russo T., Bridges S., Gurgo C., Salvatore F., and Cimino F., 1983a, Determination of pseudouridine present in tRNA and in acid soluble extract of thymic murine lymphoma. Abstracts of 15th F.E.B.S. Meeting, Bruxelles, p. 313.Google Scholar
  37. Russo T. and Cimino F., 1983b, High performance liquid chromatography analysis of nucleoside composition of tRNA. Abstracts of 3rd International Symposium on HPLC of Proteins, Peptides and polynucleotides, p. 24.Google Scholar
  38. Russo T., Colonna A., Salvatore F., Cimino F., Bridges S., and Gurgo C., 1983c, Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma. Cancer Res.,in press.Google Scholar
  39. Salvatore F., Colonna A., Costanzo F., Russo T., Esposito F., and F. Cimino, 1983a, Modified nucleosides in body fluids of tumor-bearing patients, Recent Results Cancer Res. 84: 360.PubMedGoogle Scholar
  40. Salvatore F., Russo T., Colonna A., Cimino L., Mazzacca G., and Cimino F., 1983b, Pseudouridine determination in blood serum as tumor marker, Cancer Detec. Prey. 6: in press.Google Scholar
  41. Shimizu M., and Fushimura S., 1978, Studies on the abnormal excretion of pyrimidine nucleosides in the urine of Yoshida ascites sarcoma-bearing rats, Biochim. Biophys, Acta 517: 277.Google Scholar
  42. Speer J., Gehrke C. W., Kuo K. C., Waalkes T. P., Borek E., 1979, tRNA breakdown products as markers for cancer, Cancer 44: 2120.PubMedCrossRefGoogle Scholar
  43. Thomale J., and Nass G., 1982, Elevated urinary excretion of RNA catabolites as an early signal of tumor development in mice. Cancer Letters 15: 149.PubMedCrossRefGoogle Scholar
  44. Tormey D. C., Waalkes T. P., Gehrke C. W., 1980, Biological markers in breas 9rcinoma. Clinical correlation with pseudouridine, N,N -dimethylguanosine and 1-methylinosine, J. Surg. Oncol. 14: 267.PubMedCrossRefGoogle Scholar
  45. Trewyn R. W., Glaser R., Kelly D. R., Jakson D. G., Graham W. P., and Speicher C. E., 1982, Elevated nucleoside excretion by patients with nasopharyngeal carcinoma, Cancer 49: 2513.PubMedCrossRefGoogle Scholar
  46. Waalkes T. P., Gehrke C. W., Zumwalt R. W., Chang S. Y., Lakings D.B., Tormey D. C., Ahmann D. L., Moertel C. G., 1975, The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer, Cancer 36: 390.PubMedCrossRefGoogle Scholar
  47. Waalkes T. P., Abeloff M. D., Ettinger D. S., Woo K. B., Gehrke C. W., Kuo K. C., Borek E., 1982, Biological markers and small cell carcinoma of the lung. A clinical evaluation of urinary ribonucleosides, Cancer 50: 2457.PubMedCrossRefGoogle Scholar
  48. Weissman B., Bromberg P. A. and Guttman A. B., 1957, The purine bases of human urine. Separation and identification. J. Biol. Chem. 224: 407.Google Scholar
  49. Weissman S. M., Lewis M. and Karon M., 1963, Pseudouridine metabolism. Excretion of pseudouridine and other nitrogenous metabolites in chronic leukemia, Blood 22: 657.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Filiberto Cimino
    • 1
  • Tommaso Russo
    • 1
  • Alfredo Colonna
    • 1
  • Francesco Salvatore
    • 1
  1. 1.Istituto di Scienze Biochimiche, II Facoltà di Medicina e ChirurgiaUniversità degli Studi di NapoliNapoliItaly

Personalised recommendations